Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Conditions
- Interventions
- First Posted Date
- 2015-08-14
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 124
- Registration Number
- NCT02523014
- Locations
- 🇺🇸
Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods, Michigan, United States
🇺🇸Henry Ford Saint John Hospital - Breast, Grosse Pointe Woods, Michigan, United States
Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone
- Conditions
- Interventions
- First Posted Date
- 2015-08-05
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 11
- Registration Number
- NCT02516423
- Locations
- 🇺🇸
Saint Luke's Mountain States Tumor Institute - Nampa, Nampa, Idaho, United States
🇺🇸Illinois CancerCare-Carthage, Carthage, Illinois, United States
🇺🇸Illinois CancerCare-Galesburg, Galesburg, Illinois, United States
Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases
- Conditions
- Interventions
- First Posted Date
- 2015-07-07
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 19
- Registration Number
- NCT02490878
- Locations
- 🇺🇸
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
🇺🇸Memorial Health University Medical Center, Savannah, Georgia, United States
🇺🇸Summit Cancer Care-Memorial, Savannah, Georgia, United States
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 5
- Registration Number
- NCT02485834
- Locations
- 🇺🇸
Regional Hematology and Oncology PA, Newark, Delaware, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Englewood Hospital and Medical Center, Englewood, New Jersey, United States
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Conditions
- Interventions
- First Posted Date
- 2015-03-02
- Last Posted Date
- 2023-08-31
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 420
- Registration Number
- NCT02375204
- Locations
- 🇺🇸
Loma Linda University Medical Center, Loma Linda, California, United States
🇺🇸USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Hackensack University Medical Center, Hackensack, New Jersey, United States
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
- First Posted Date
- 2015-01-28
- Last Posted Date
- 2021-07-26
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 405
- Registration Number
- NCT02349412
- Locations
- 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸Queen's Medical Center, Honolulu, Hawaii, United States
🇺🇸UC San Diego Moores Cancer Center, La Jolla, California, United States
Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-12-09
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 195
- Registration Number
- NCT02311907
- Locations
- 🇺🇸
Northside Hospital, Atlanta, Georgia, United States
🇺🇸Saint Joseph's Hospital of Atlanta, Atlanta, Georgia, United States
🇺🇸Pennsylvania Hospital, Philadelphia, Pennsylvania, United States
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
- First Posted Date
- 2014-09-26
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 15
- Registration Number
- NCT02249949
- Locations
- 🇺🇸
Northside Hospital, Atlanta, Georgia, United States
🇺🇸Rush - Copley Medical Center, Aurora, Illinois, United States
🇺🇸Illinois CancerCare-Canton, Canton, Illinois, United States
Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy
- Conditions
- Interventions
- First Posted Date
- 2014-09-01
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 275
- Registration Number
- NCT02229539
- Locations
- 🇺🇸
Providence Saint Joseph Medical Center/Disney Family Cancer Center, Burbank, California, United States
🇺🇸Rocky Mountain Cancer Centers-Longmont, Longmont, Colorado, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
Inolitazone Dihydrochloride and Paclitaxel in Treating Patients With Advanced Anaplastic Thyroid Cancer
- Conditions
- Interventions
- First Posted Date
- 2014-06-02
- Last Posted Date
- 2023-04-27
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 19
- Registration Number
- NCT02152137
- Locations
- 🇺🇸
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
🇺🇸Minor and James Medical PLLC, Seattle, Washington, United States
🇺🇸Swedish Medical Center-Cherry Hill, Seattle, Washington, United States